scispace - formally typeset
K

Kemal Dagalp

Researcher at Military Medical Academy

Publications -  46
Citations -  1984

Kemal Dagalp is an academic researcher from Military Medical Academy. The author has contributed to research in topics: Clarithromycin & Population. The author has an hindex of 19, co-authored 46 publications receiving 1888 citations.

Papers
More filters
Journal ArticleDOI

Metformin in the treatment of patients with non-alcoholic steatohepatitis.

TL;DR: This work has shown that insulin resistance is the major pathogenic mechanism in the development of non‐alcoholic steatohepatitis and the use of insulin to treat this condition is recommended.
Journal ArticleDOI

Serum leptin levels in patients with nonalcoholic steatohepatitis.

TL;DR: The serum leptin levels were significantly higher in patients with NASH, while they were not affected by chronic hepatitis, and this elevation is out of proportion to BMI of these patients and may be related to hyperlipidemia in most.
Journal ArticleDOI

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.

TL;DR: The results concerning correlations suggest that disturbances in BMI, body fat, and lipid metabolism may contribute to altered oxidative status in NAFLD, and insulin resistance may be related to decreased antioxidants inNAFLD as well as products of lipid peroxidation.
Journal ArticleDOI

Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease.

TL;DR: High levels of GSH-Px, which is response against oxidative stress, indicates the increase of free radicals in IBD, while normal plasma MDA levels suggest the clearance offree radicals without leading to lipid peroxidation, reveals that there is an existing antioxidant capacity despite oxidative stress in patients with IBD.
Journal ArticleDOI

Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.

TL;DR: The main aim of the present study was to evaluate the clinical significance of plasma homocysteine concentrations in patients with non‐alcoholic fatty liver disease.